We recently made a list of Goldman Sachs’ Top Fund Manager Stock Picks: 25 Best Overweight Stocks. In this piece, we will ...

Many Medicare beneficiaries are facing steep hikes in Part D premiums for 2025, with some states seeing increases of up to ...

For the most part, most insurances are accepted. KDKA-TV asked Point Park University Professor Dr. Archish Maharaja about ...

The Texas attorney general has sued leading insulin manufacturers and pharmacy benefit managers (PBMs), accusing them of ...

The litigation comes as pharmacy benefit managers Express Scripts, CVS Caremark and Optum Rx face growing criticism over ...

Humana Inc.'s stock was up 2% Friday after three straight sessions of declines, but investors paying attention to the performance of its bonds on Thursday may have had something of a heads-up on the ...

Cigna and HCA Houston Healthcare have extended their current contract until Oct. 8 amid ongoing negotiations, the Houston Business Journal reported Oct. 3. 1. Negotiations dragged into the eleventh ...

In 2023, about 80% of all prescription drug claims in the U.S. were processed by only three companies. VC-backed Rightway CEO ...

UPMC said wants to make access to care outside of the emergency room more convenient and less costly, especially for ...

The FDA approved a new strength of a trastuzumab biosimilar; UnitedHealth will remove reference adalimumab from some ...

Spinal cord stimulators are designed to address back pain and can be used as part of a patient's treatment plan.

UnitedHealth Group and Centene's Ambetter are expanding sales of individual coverage under the Affordable Care Act into ...